Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A de Graeff

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Molecular and Cellular Cardiology|December 1, 1986
Effects of diltiazem on reperfusion-induced arrhythmias in vitro and in vivoW H van Gilst, P A de Graeff, J H Kingma, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1986
Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heartP A De Graeff, W H Van Gilst, C D De Langen, et al.
European Journal of Pharmacology|April 13, 1984
Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusionW H Van Gilst, P A De Graeff, J H Kingma, et al.
Journal of Human Hypertension|June 1, 1989
Cardiac arrhythmias--a new indication for angiotensin-converting enzyme inhibitors?H Wesseling, P A de Graeff, W H van Gilst, et al.
Nephron|January 1, 1985
Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-upP A de Graeff, J Dankert, D de Zeeuw, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 17, 2000
[Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?]P P Koopmans, P A de Graeff, B J van Zwieten-Boot, et al.
Blood Pressure|May 31, 2002
Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patientsW F Terpstra, J F May, A J Smit, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?W H van Gilst, J van Wijngaarden, E Scholtens, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2001
Co-morbidity of 'clinical trial' versus 'real-world' patients using cardiovascular drugsN F Wieringa, R Vos, G T van der Werf, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig modelP A de Graeff, W H van Gilst, K Bel, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Molecular and Cellular Cardiology|December 1, 1986
Effects of diltiazem on reperfusion-induced arrhythmias in vitro and in vivoW H van Gilst, P A de Graeff, J H Kingma, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1986
Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heartP A De Graeff, W H Van Gilst, C D De Langen, et al.
European Journal of Pharmacology|April 13, 1984
Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusionW H Van Gilst, P A De Graeff, J H Kingma, et al.
Journal of Human Hypertension|June 1, 1989
Cardiac arrhythmias--a new indication for angiotensin-converting enzyme inhibitors?H Wesseling, P A de Graeff, W H van Gilst, et al.
Nephron|January 1, 1985
Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-upP A de Graeff, J Dankert, D de Zeeuw, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 17, 2000
[Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?]P P Koopmans, P A de Graeff, B J van Zwieten-Boot, et al.
Blood Pressure|May 31, 2002
Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patientsW F Terpstra, J F May, A J Smit, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?W H van Gilst, J van Wijngaarden, E Scholtens, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2001
Co-morbidity of 'clinical trial' versus 'real-world' patients using cardiovascular drugsN F Wieringa, R Vos, G T van der Werf, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig modelP A de Graeff, W H van Gilst, K Bel, et al.
Pageof 9